Tag Archives: EvOx Therapeutics

Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of these payloads using Evox's proprietary exosome technologyPartnership encompasses up to five rare disease targets, including...

Evox Therapeutics, a leading exosome therapeutics company, a leading exosome therapeutics company, today announces that it has secured £655,000 in funding from Duchenne UK. The grant will be invested to support exploration of the Company’s exosome-based therapeutic platform to deliver ...

Proceeds will advance transformative exosome therapeutics pipeline towards the clinic, continued expansion of world-leading exosome platform for delivery of different drug modalities Evox...

Evox Therapeutics Ltd, a leading exosome therapeutics company, today announces that it has entered into a research collaboration with Boehringer

Evox Therapeutics, a leading exosome therapeutics company, is pleased to announce the appointment of Dr Antonin “Tony” de Fougerolles as Chief Executive Officer, taking over from acting Chief Executive Officer Dr Per Lundin. Tony will help to drive Evox towards ...

Department of Physiology, Anatomy and Genetics, Oxford Grade 7: Salary in the range £31,076 – £33,943 p.a. Applications are sought for a full-time Postdoctoral Research Scientist to be based in the Department of Physiology, Anatomy and Genetics, Oxford. The successful ...

Oxford spinout EvOx Therapeutics will harness the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune ...